Condensed Consolidated Cash Flow Statements (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 03, 2021	Sep. 27, 2020
Cash flows from operating activities:
Net income (loss)	$ 114,030	$ (62,019)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization	65,028	80,620
Share-based compensation	18,242	13,650
Asset impairment	9,283	113,007
Loss on debt extinguishment	5,715	0
Gain on disposal of business	0	(2,743)
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes, acquired businesses and disposals:
Receivables	(128,997)	35,645
Inventories	(58,900)	(9,327)
Accounts payable	73,740	(69,579)
Accrued liabilities	17,796	(11,646)
Income taxes	5,159	(30,416)
Other assets	(1,794)	1,860
Other liabilities	(17,383)	(20,363)
Net cash provided by operating activities	101,919	38,689
Cash flows from investing activities:
Cash from (used for) business acquisitions, net of cash acquired	(73,749)	590
Capital expenditures	(55,569)	(56,809)
Purchase of intangible assets	(3,650)	0
Proceeds from disposal of tangible assets	3,249	3,090
Proceeds from disposal of businesses, net of cash sold	10,798	50,051
Net cash used for investing activities	(118,921)	(3,078)
Cash flows from financing activities:
Payments under borrowing arrangements	(360,304)	(190,000)
Debt issuance costs paid	(7,785)	0
Cash dividends paid	(6,740)	(6,800)
Payments under financing lease obligations	(3,116)	(154)
Withholding tax payments for share-based payment awards	(2,103)	(1,331)
Payments under share repurchase program	0	(35,000)
Payment of earnout consideration	0	(29,300)
Borrowings under credit arrangements	356,010	190,000
Net cash used for financing activities	(24,038)	(72,585)
Effect of foreign currency exchange rate changes on cash and cash equivalents	(3,201)	2,586
Decrease in cash and cash equivalents	(44,241)	(34,388)
Cash and cash equivalents, beginning of period	501,994	425,885
Cash and cash equivalents, end of period	$ 457,753	$ 391,497